Point mutation in the parkin gene on patients with Parkinson’s disease

Abstract

To investigate the distribution of possible novel mutations from parkin gene in variant subset of patients with Parkinson’s disease (PD) in China and explore whether parkin gene plays an important role in the pathogenesis of PD, 70 patients were divided into early-onset group and late-onset group; 70 healthy subjects were included as controls. Genomic DNA from 70 normal controls and from those of PD patients were extracted from peripheral blood leukocytes by using standard procedures. Mutations of parkin gene (exon 1–12) in all the subjects were screened by PCR-single strand conformation polymorphism (SSCP), and further sequencing was performed in the samples with abnormal SSCP results, in order to confirm the mutation and its location. A new missense mutation Gly284Arg in a patient and 3 abnormal bands in SSCP electrophoresis from samples of another 3 patients were found. All the DNA variants were sourced from the samples of the patients with early-onset PD. It was concluded that Parkin point mutation also partially contributes to the development of early-onset Parkinson’s disease in Chinese.

Keywords

Parkinson’s disease / parkin gene / point mutation

References

[1] KitadaT, AsakawaS, HattoriN, et al. . Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature, 1998, 392605-605

[2] LückingC B, DürrA, BonifatiV, et al. . Association between early-onset parkinson’s disease and mutations in the parkin gene. N Engl J Med, 2000, 3421560-1560

[3] HattoriN, KitadaT, MatsumineH, et al. . Molecular genetic analysis a novel parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the parkin gene in affected individuals. Ann Neurol, 1998, 44935-935

[4] HattoriN, Matsumine, AsakawaS, et al. . Point mutation (Thr240Arg and Ala311Stop) in the parkin gene. Biochem Biophy Res Commun, 1998, 249754-754

[5] MaruyamaM, IkeuchiT, SaitoM, et al. . Novel mutations, pseudo-dominant inheritance, and possible familial affects in patients with autosomal recessive juvenile parkinsonism. Ann Neurol, 2000, 48245-245

[6] UjikeH, YamamotoM, KanzakiA, et al. . Prevalence of homozygous deletions of the parkin gene in a cohort of patients with sporadic and familial Parkinson’s disease. Mov Disord, 2001, 16111-111

[7] ShimuraH, HattoriN, KuboS, et al. . Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet, 2000, 25(3): 302-302

[8] ZhangY, GaoJ, ChungK K, et al. . Parkin, functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci USA, 2000, 97(24): 13354-13354

[9] ShimuraH, SchlossmacherM G, HattoriN, et al. . Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson’s disease. Science, 2001, 293(5528): 263-263

[10] PolymeropoulosM H, LavedanC, LeroyE, et al. . Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science, 1997, 276(5321): 2045-2045

[11] SolanoS, MillerD, AugoodS, et al. . Expression of α-synuclein, parkin, and ubiquitin carboxy-terminal hydrolase L1 mRNA in human brain: genes associated with familial Parkinson’s disease. Ann Neurol, 2000, 47201-201